The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,2S)-1-(3-fluoro-4-((2-phenylquinolin-4-yl)methoxy)benzyl)-N2-hydroxy-N1,N1-dimethylcyclopropane-1,2-dicarboxamide ID: ALA496309
PubChem CID: 44580801
Max Phase: Preclinical
Molecular Formula: C30H28FN3O4
Molecular Weight: 513.57
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)C(=O)[C@@]1(Cc2ccc(OCc3cc(-c4ccccc4)nc4ccccc34)c(F)c2)C[C@@H]1C(=O)NO
Standard InChI: InChI=1S/C30H28FN3O4/c1-34(2)29(36)30(17-23(30)28(35)33-37)16-19-12-13-27(24(31)14-19)38-18-21-15-26(20-8-4-3-5-9-20)32-25-11-7-6-10-22(21)25/h3-15,23,37H,16-18H2,1-2H3,(H,33,35)/t23-,30+/m1/s1
Standard InChI Key: QCSQWZYXJSYMSJ-DJUQAAIZSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
10.8480 2.0937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6738 2.0937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2609 2.8106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2399 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3804 2.5207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1035 2.1249 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3638 3.3487 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2418 0.6729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5243 0.2631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5249 -0.5619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2410 -0.9749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9581 -0.5568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9541 0.2669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0472 1.8810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4646 2.4662 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8317 1.0838 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6665 2.2542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2430 -1.8007 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5288 -2.2153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5308 -3.0411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5338 -4.6916 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2504 -4.2726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2452 -3.4489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8171 -4.2796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8189 -3.4578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1091 -3.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3970 -3.4571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3992 -4.2822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1096 -4.6891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1222 1.2994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8091 2.5540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9653 -4.6795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9689 -5.5064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6856 -5.9150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3993 -5.4978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3918 -4.6678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6744 -4.2629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6752 -0.9664 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8 9 2 0
18 19 1 0
1 3 1 0
19 20 1 0
20 25 2 0
9 10 1 0
24 21 2 0
2 5 1 0
21 22 1 0
10 11 2 0
22 23 2 0
23 20 1 0
11 12 1 0
24 25 1 0
2 1 1 0
25 26 1 0
12 13 2 0
26 27 2 0
13 8 1 0
27 28 1 0
5 6 1 0
28 29 2 0
29 24 1 0
1 14 1 1
6 30 1 0
5 7 2 0
6 31 1 0
14 15 1 0
3 2 1 0
32 33 2 0
14 16 2 0
33 34 1 0
4 8 1 0
34 35 2 0
15 17 1 0
35 36 1 0
2 4 1 1
36 37 2 0
37 32 1 0
22 32 1 0
11 18 1 0
12 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 513.57Molecular Weight (Monoisotopic): 513.2064AlogP: 4.76#Rotatable Bonds: 8Polar Surface Area: 91.76Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.86CX Basic pKa: 3.66CX LogP: 4.64CX LogD: 4.63Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -0.76
References 1. Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X.. (2008) Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket., 18 (21): [PMID:18835710 ] [10.1016/j.bmcl.2008.09.045 ]